Concepedia

Publication | Closed Access

PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression

DOI

39

Citations

25

References

2020

Year

Patrik Fazio, Cheryl Fitzer‐Attas, Ladislav Mrzljak, Juliana Bronzova, Sangram Nag, John Harley Warner, G. Bernhard Landwehrmeyer, Nabil Al‐Tawil, Christer Halldin, Anton Forsberg,
Movement Disorders

Abstract

[<sup>18</sup> F]MNI-659 PET imaging is a biologically plausible biomarker of Huntington's disease progression that is more sensitive than the dopamine-receptor and volumetric methods currently used. © 2020 International Parkinson and Movement Disorder Society.

References

YearCitations

Page 1